# ALVAIZ
> **NDA216774** · New Drug Application · Sponsor: TEVA PHARMS INC · Approved 2023-11-29
## Drug
- **FDA Application Number:** NDA216774
- **Application type:** New Drug Application
- **Brand name:** ALVAIZ
- **Generic name:** ELTROMBOPAG
- **Active ingredients:** ELTROMBOPAG CHOLINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS INC
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2023-11-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216774)
---
*MORVS · CC0 1.0*